Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation

Science China Life Sciences

Volumn 54, Issue 12, 2011, Pages 1097-1102

  Zhang, Ying ^a   Dong, De Li ^a   Yang, Bao Feng ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

atrial fibrillation; microRNA; remodeling

Indexed keywords

MICRORNA;

GENETICS; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HISTOLOGY; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ATRIAL FIBRILLATION; HEART ATRIA; HUMANS; MICRORNAS;

ANIMALIA;

EID: 84862932007     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-011-4241-3     Document Type: Review

References (40)

1. Kannel W B, Wolf P A, Benjamin E J, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol, 1998, 82: 2N-9N.
2. Nattel S. New ideas about atrial fibrillation 50 years on. Nature, 2002, 415: 219-226.
3. Bosch R F, Zeng X, Grammer J B, et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res, 1999, 44: 121-131.
4. Sun H, Chartier D, Leblanc N, et al. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res, 2001, 49: 751-761.
5. Oh S, Kim K B, Ahn H, et al. Remodeling of ion channel expression in patients with chronic atrial fibrillation and mitral valvular heart disease. Korean J Intern Med, 2010, 25: 377-385.
6. + current densities and Kv1. 5 expression are reduced in chronic human atrial fibrillation. Circ Res, 1997, 80: 772-781.
7. Ravens U, Wettwer E. Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovasc Res, 2011, 89: 776-785.
8. + currents in right atrial myocytes of human atrial fibrillation. Chin J Pathophysiol, 2005, 21: 77-80.
9. Chiou C W, Eble J N, Zipes D P. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes: the third fat pad. Circulation, 1997, 95: 2573-2584.
10. Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol, 1997, 273: H805-816.
11. Ellinor P T, Nam E G, Shea M A, et al. Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm, 2008, 5: 99-105.
12. Balana B, Dobrev D, Wettwer E, et al. Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. J Mol Cell Cardiol, 2003, 35: 1399-1405.
13. Gaspo R, Bosch R F, Bou-Abboud E, et al. Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation. Circ Res, 1997, 81: 1045-1052.
14. Allessie M A, Boyden P A, Camm A J, et al. Pathophysiology and prevention of atrial fibrillation. Circulation, 2001, 103: 769-777.
15. Brundel B J, van Gelder I C, Henning R H, et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation, 2001, 103: 684-690.
16. Ausma J, Dispersyn G D, Duimel H, et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol, 2000, 32: 355-364.
17. 2+-channel, beta-adrenorecptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation. Basic Res Cardiol, 2001, 96: 82-90.
18. Greiser M, Halaszovich C R, Frechen D, et al. Pharmacological evidence for altered src kinase regulation of I (Ca, L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol, 2007, 375: 383-392.
19. Brundel B J, van Gelder I C, Henning R H, et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol, 2001, 37: 926-932.
20. Grammer J B, Bosch R F, Kühlkamp V, et al. Molecular remodeling of Kv4. 3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol, 2000, 11: 626-633.
21. + current densities and Kv1. 5 expression are reduced in chronic human atrial fibrillation. Circ Res, 1997, 80: 772-781.
22. Li D, Fareh S, Leung T K, et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation, 1999, 100: 87-95.
23. Xiao H D, Fuchs S, Campbell D J, et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol, 2004, 165: 1019-1032.
24. Litchenberg W H, Norman L W, Holwell A K, et al. The rate and anisotropy of impulse propagation in the postnatal terminal crest are correlated with remodeling of Cx43 gap junction pattern. Cardiovasc Res, 2000, 45: 379-387.
25. Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res, 2002, 54: 361-379.
26. Everett T H 4th, Li H, Mangrum J M, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation, 2000, 102: 1454-1460.
27. Lewis B P, Shih I H, Jones-Rhoades M W, et al. Prediction of mammalian microRNA targets. Cell, 2003, 115: 787-798.
28. Hawkins P G, Morris K V. RNA and transcriptional modulation of gene expression. Cell Cycle, 2008, 7: 602-607.
29. Lu Y, Zhang Y, Wang N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation, 2010, 122: 2378-2387.
30. Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med, 2007, 13: 486-491.
31. Girmatsion Z, Biliczki P, Bonauer A, et al. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm, 2009, 6: 1802-1809.
32. Xiao J, Liang D, Zhang Y, et al. MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiol Genomics, 2011, 43: 655-664.
33. Shan H, Zhang Y, Lu Y, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res, 2009, 83: 465-472.
34. van Rooij E, Sutherland L B, Thatcher J E, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA, 2008, 105: 13027-13032.
35. Duisters R F, Tijsen A J, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res, 2009, 104: 170-178.
36. van Rooij E, Sutherland L B, Qi X, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 2007, 316: 575-579.
37. Bukowska A, Schild L, Keilhoff G, et al. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia. Exp Biol Med, 2008, 233: 558-574.
38. Cordes K R, Sheehy N T, White M P, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 2009, 460: 705-710.
39. Schlesinger J, Schueler M, Grunert M, et al. The cardiac transcription network modulated by Gata4, Mef2a, Nkx2. 5, Srf, histone modifications, and microRNAs. PLoS Genet, 2011, 7: e1001313.
40. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun, 2010, 391: 73-77.